Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance.

International journal of cancer - 15 Dec 2009

Wang Wei, Yuasa Takeshi, Tsuchiya Norihiko, Ma Zhiyong, Maita Shinya, Narita Shintaro, Kumazawa Teruaki, Inoue Takamitsu, Tsuruta Hiroshi, Horikawa Yohei, Saito Mitsuru, Hu Weilie, Ogawa Osamu, Habuchi Tomonori

Abstract excerpt

Mel-18 is a member of the polycomb group (PcG) proteins, which are chromatin regulatory factors and play important roles in development and oncogenesis. This study was designed to investigate the clinical and prognostic significance of Mel-18 in patients with prostate cancer. A total of 539 native Japanese subjects consisting of 393 prostate cancer patients and 146 controls were enrolled in this study. Mel-18...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Pairing
Share to Bone Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to Immunoenzyme Techniques

Share to Polycomb Repressive Complex 1

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 19585577
DOI: 10.1002/ijc.24721

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance.PMID 19585577Read ↗

Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines.Semantic proximity Read ↗

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.Semantic proximity Read ↗

The castration-resistant prostate cancer-associated SNP rs11067228 facilitates neuroendocrine differentiation through an enhancer-mediated chromatin interaction with SRRM4.Semantic proximity Read ↗

NKAIN2 functions as a novel tumor suppressor in prostate cancer.Semantic proximity Read ↗

Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancerSemantic proximity Read ↗

BAP18 coactivates androgen receptor action and promotes prostate cancer progressionSemantic proximity Read ↗

An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.Semantic proximity Read ↗

PRDM16 is associated with evasion of apoptosis by prostatic cancer cells according to RNA interference screeningSemantic proximity Read ↗

miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.Semantic proximity Read ↗

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progressionSemantic proximity Read ↗

The RNA Helicase p68 Is a Novel Androgen Receptor Coactivator Involved in Splicing and Is Overexpressed in Prostate CancerSemantic proximity Read ↗

Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.